Botulinum toxin type a injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: A pilot study

Journal of Pediatric Orthopaedics

Volumn 29, Issue 5, 2009, Pages 427-434

  Hamdy, Reggie C ^a,c   Montpetit, Kathleen ^c   Raney, Ellen M ^c   Aiona, Michael D ^c   Fillman, Ramona R ^c   MacKenzie, William ^e   McCarthy, James ^c   Chafetz, Ross S ^c   Thomas, Susan Sienko ^c   Tamayo, Cynthia M ^c   Littleton, Aaron G ^e   Ruck Gibis, Joanne ^c   Susan, Takahashi N ^c   Rinaldi, Mario ^c   Finley, G Allen ^d   Platt, Robert W ^b   Dahan Oliel, Noémi ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Botulinum toxin type A; Distraction; External fixators; Lower extremity; Osteogenesis; Pain; Quality of life

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; DIAZEPAM; FENTANYL; HYDROMORPHONE; MORPHINE; PLACEBO; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; ILIZAROV TECHNIQUE; LEG LENGTHENING; LIMB DEFORMITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PILOT STUDY; PIN SITE CARE; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SCORING SYSTEM; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILIZAROV TECHNIQUE; LEG LENGTH INEQUALITY; LOWER EXTREMITY; LOWER EXTREMITY DEFORMITIES, CONGENITAL; MALE; NEUROMUSCULAR AGENTS; PAIN, POSTOPERATIVE; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; YOUNG ADULT;

EID: 67650866513     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/BPO.0b013e3181aad628     Document Type: Article

References (40)

1. Wilson GN. Heritable limb deficiencies. In: Herring JA, Birch JG, eds. The Child With a Limb Deficiency. Rosemont, IL: Amercian Academy of Orthopaedic Surgeons; 1998:39-51.
2. Ramaker RR, Lagro SWJ, Roermund PMV, et al. The psychological and social functioning of 14 children and 12 adolescents after Ilizarov leg lengthening. Acta Orthop Scan. 2000;71:55-89.
3. Paley D. Current techniques of limb lengthening. J Pediatr Orthop. 1988;8:73-92.
4. Ilizarov GA. The tension-stress effect of the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop. 1989;238:249-281.
5. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: part II. The influence of the rate and frequency of distraction. Clin Orthop. 1989;239:263-285.
6. McKee MD, Yoo D, Schemithsch EH. Health status after Ilizarov reconstruction of post-traumatic lower-limb deformity. J Bone Joint Surg Am. 1998;80-B:360-364.
7. Noonan KJ, Leyes M, Forriol F, et al. Distraction osteogenesis of the lower extremity with use of monolateral external fixation. J Bone Joint Surg. 1981;80:793-806.
8. Maffulli N, Lombari C, Matarazzo L, et al. A review of 240 patients undergoing distraction osteogenesis for congenital post-traumatic or post infective lower limb length discrepancy. J Am Coll Surg. 1996; 182:394-402.
9. De Bastiani G, Aldegheri R, Renzi-Brivio L, et al. Limb lengthening by callus distraction (callotasis). J Pediatr Orthop. 1987;7:129-134.
10. Garcia-Cimbrelo E, Olsen B, Ruiz-Yague M, et al. Ilizarov technique. Results and difficulties. Clin Ortho Rel Res. 1992;283: 116-123.
11. Hamdy R, Fassier F, Lachapelle D, et al. The Use of the Ilizarov Method in Children for Limb Lengthening. Medscape OrthopSports Med. 1998;2:1-17.
12. Paley D. Problems, obstacles, and complications oflimb lengthening by the Ilizarov technique. Clin Orthop Rel Res. 1990;250:81-104.
13. Eldridge J, Bell D. Problems with substantial limb lengthening. Orthop Clin North Am. 1991;22:625-631.
14. Young N, Bell DF, Anthony A. Pediatric pain patterns during Ilizarov treatment of limb discrepancy and angular deformity. J Pediatr Orthop. 1994;14:394-412.
15. Brin M, Aoki K. Botulinum toxin type A: pharmacology. In: Mayer NH, Simpson DM, eds. Spasticity: Etiology, Evaluation, Management and the Role of Botulinum Toxin. New York: We Move; 2002: 110-124.
16. Tsui J, Eisen A, Mak E, et al. A pilot study on the use ofBotulinum toxin in spasmodic torticolis. Can J Neurol Sci. 1985;12:314-316.
17. Schulte-Matler W, Blersch W, Przywara S, et al. Botulinum toxin A and the cutaneous nociception in humans. Abstracts of the International Conference 2002: basic and therapeutic aspects of botulinum and tetanus toxins. Arch Pharmacol. 2002;365:R39.
18. Schaible H, von Banchet SG, Ebersberger A, et al. Involvement of CGRP in nociceptive processing and hyperalgesia: effects on spinal and dorsal root ganglion neurons. In: Brune K, Handwerker H, eds. Hyperalgesia: Molecular Mechanisms and Clinical Implications. Seattle, WA: Progress in pain research and management; 2004: 201-228.
19. Jankovic J, Vuong M, Ahsan J. Comparison of efficacy and immunogenicity of originial versus current botulinum toxin in cervical dystonia. Neurology. 2003;60:1186-1188.
20. Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain. 2002;18:S142-S146.
21. Anderson ER Jr. Proper dose, preparation, and storage of botulinum neurotoxin serotype A. Am J Health Syst Pharm. 2004;61:S24-S29.
22. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain. 2002;18:S177-S181.
23. Smith H, Audette J, Royal M. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18:S147-S154.
24. Lang A. Botulinum toxin type A therapy in chronic pain disorders. Arch Phys Med Rehabil. 2003;84:S69-S73.
25. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res. 2005;5:132-138.
26. Fehlings D, Yeung K-K, Teplicky R. The use of botulinum toxin in children with muscle stiffness: An update [CanChild Web site]. 2002. Available at: http://www. canchild.ca/Default.aspx?tabid = 135. Accessed October 23, 2008.
27. Dallal GE. Randomization.com. [Randomization.com Web site]. July 15, 2008. Available at: http://randomization.com. Accessed October 23, 2008.
28. Hamdy R, Montpetit K, Ruck-Gibis J, et al. Safety and efficacy of botox injection in alleviating post-operative pain and improving quality of life in lower extremity limb lengthening and deformity correction. Trials. 2007;8:27.
29. Hicks C, von Baeyer C, Spafford P, et al. The Faces Pain Scale- revised: toward a common metric in pediatric pain measurement. Pain. 2001;93:173-183.
30. von Baeyer C. The Faces Pain Scale-revised (FPS-R). [Centre for Pediatric Pain Research]. August 2007. Available at: http://www.pediatric-pain.ca/ sourcebook/facesPainScale.html. Accessed October 23, 2008.
31. McCaffery M, Pasero C. Chapter 3: Assessment: Underlying Complexities, Misconceptions, and Practical Tools. Pain - Clinical Manual. 2nd ed. St. Louis, MO: Mosby, Inc.; 1999:35-99.
32. Savedra M, Tesler M, Holzemer W, et al. Adolesdent Pediatric Pain Tool (APPT) Preliminary User's Manual. San Francisco, CA: University of California, San Francisco, School of Nursing; 1989.
33. Varni J, Seid M, Kurtin P. PedsQL 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory(TM) Version 4.0 Generic Core Scales in Healthy and Patient Populations. Med Care. 2001;39: 800-812.
34. Varni J, Burwinkle T, Seid M, et al. The PedsQL4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329-341.
35. Novacheck T, Stout J, Tervo R. Reliability and validity of the Gillette functional assessment questionnaire as an outcome measure in children with walking disabilities. J Pediatr Orthop. 2000;20: 75-81.
36. Powell CV, Kelly A-M, Williams A. Determining the minimum clinically significant difference in visual analog pain score for children. Ann Emerg Med. 2001;37:28-31.
37. Martin L, Farrell M, Lambrenos K, et al. Living with the Ilizarov frame: adolescent perceptions. J Adv Nurs. 2003;43: 478-487.
38. Ghoneem HF, Wright JG, Cole WG, et al. The Ilizarov method for correction of complex deformities. Psychological and functional outcomes. J Bone Joint Surg Am. 1996;78:1480-1485.
39. Morton AA. Psychological considerations in the planning of staged reconstruction of limb deficiencies. In: Herring JA, Birch JG, eds. The Child With a Limb Deficiency. Rosemont, IL: Amercian Academy of Orthopaedic Surgeons; 1998:195-204.
40. Olabisi R, Best TM, Vanderby R Jr, et al. Effects of botulinum toxin A on functional outcome during distraction osteogenesis. J Orthop Res. 2007;25:656-664.